News

Different groups of TB bacteria exist worldwide with different regional distribution: some are generalists and can be found on many continents, while others are very limited in their spread. An

The novel active agent HY-133, which was developed by HYpharm and prepared for clinical trials in collaboration with the German Center for Infection Research (DZIF) and universities in Tübingen

The motto of this year's World Hepatitis Day, proclaimed annually on 28 July by the World Health Organisation (WHO), is “It's time to act". Hundreds of millions of people worldwide are affected by

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus-infected cells but are inactive. An international team led by Percy Knolle and Ulrike Protzer at the

In the years of the COVID-19 pandemic, the effectiveness of government-ordered measures to contain the pandemic, such as regular testing and the wearing of medical masks, was repeatedly called into

UNITE4TB—an international public-private partnership aiming to accelerate the development of innovative tuberculosis treatments—has announced the successful completion of participant recruitment for

Treatment with Linezolid, an antibiotic that is used against multi-resistant tuberculosis bacteria, leads to adverse drug reactions in around a quarter of patients, including certain nerve disorders

INCATE, the INCubator for Antimicrobial Therapies in Europe co-founded by the German Center for Infection Research, has been honoured with the 2024 Lighthouse Award for outstanding Transfer of

The microbiome, i.e. the microorganisms that colonise our gut and help with digestion, weighs around one and a half kilograms. It consists primarily of bacteria and also has a protective effect

Members of Parliament (MPs) from the CDU, FDP, SPD and Die Linke parties have joined forces in a parliamentary group to focus more on combating antimicrobial resistance in the future.

Antibacterial